Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Electrophilic Fluorination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover advanced electrophilic fluorination technology via patent CN102516202A. We offer scalable synthesis of high-purity N-fluoro-binaphthyl sulfonimides for pharmaceutical manufacturing.
Novel 3-step route replaces inefficient 8-step process. High yield, mild conditions, ideal for API manufacturing scale-up.
Patent CN101454272A introduces a recyclable fluoroamine for green fluorination. Discover cost reduction in fluorination manufacturing and high-purity intermediate supply.
Novel fluorine gas method for high-purity 1,7,8-trifluoro-2-naphthol. Reduces cost and complexity in electronic chemical manufacturing for display materials.
Novel green chemistry route for alpha-acyloxy thioethers using Selectfluor. Reduces toxicity and cost for pharmaceutical intermediates manufacturing.
Patent CN102040649A details a safe, cost-effective fluorination process for steroid intermediates using NFOBS/NFSI, offering significant supply chain advantages.
Patent CN108929267B reveals a high-yield, metal-free route to difluoroquinolone intermediates using Selectfluor, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN111574471B reveals a novel route for 1,3-oxazine fluorides using Selectfluor, offering cost reduction in API manufacturing and improved supply chain reliability.
Patent CN101691329B details high-selectivity electrophilic fluorination. Offers cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Patent CN107216360A details a safer Solithromycin preparation method avoiding azides, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN1571792A details a cost-effective 10-step synthesis of L-FMAU from L-arabinose using Selectfluor, offering superior yields over conventional ribose routes.
Novel 9-step route from hydrocortisone-21-acetate improves yield and reduces toxicity for difluprednate manufacturing.
Advanced synthesis of flunixin meglumine intermediate via high-pressure fluorination. Delivers high purity and scalable manufacturing for veterinary pharmaceuticals.
Patent CN109232476B reveals a Selectfluor-mediated route for N-phenyl-3-morpholine propionamide. Achieves 80% yield, replacing toxic acid chlorides for safer manufacturing.
Discover an efficient 3-step synthesis for 1-Boc-3-fluoroazetidine-3-carboxylic acid. This patent offers high yield and scalable production for API manufacturing.
Discover the novel three-step synthesis of alpha,alpha-fluorochloroarylmethyl phosphonates via Pudovik addition and electrophilic fluorination for PTPs inhibitor development.
Patent CN110028447A reveals a metal-free fluorination method offering high yield and purity. Discover supply chain advantages and cost reduction in pharmaceutical intermediate manufacturing.
Novel two-step route avoids liquid HF. High purity >99.9%. Cost-effective API intermediate manufacturing for antiviral drugs.
Novel two-step fluorination route for 5-fluorocytosine. High purity >99.9%, cost-effective, avoids HF. Ideal for API manufacturing.
Patent CN113816882B details a novel one-pot dehydration method using Selectfluor and NaI, offering a safer, high-yield alternative to toxic POCl3 processes for pharmaceutical intermediates.